|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q38803739
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010712.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q38803739
|
|
024
|
|
|
‡a
0000-0003-4768-8722
‡2
orcid
|
|
024
|
|
|
‡a
0000-0002-4650-8542
‡2
orcid
|
|
024
|
|
|
‡a
7101624354
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q38803739
|
|
043
|
|
|
‡c
ES
|
|
046
|
|
|
‡f
19520000
|
|
100
|
0 |
|
‡a
Josep Roca
‡c
researcher (ORCID 0000-0003-4768-8722)
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
Spaans onderzoeker
‡9
nl
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
investigador español
‡9
ast
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
investigador espanyol
‡9
ca
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
Forscher
‡9
de
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
ricercatore spagnolo
‡9
it
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
taighdeoir
‡9
ga
|
|
400
|
0 |
|
‡a
Josep Roca
‡c
investigador español
‡9
es
|
|
670
|
|
|
‡a
Author's A portable forced oscillation device for respiratory home monitoring.
|
|
670
|
|
|
‡a
Author's A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.
|
|
670
|
|
|
‡a
Author's A systems medicine clinical platform for understanding and managing non- communicable diseases.
|
|
670
|
|
|
‡a
Author's Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios
|
|
670
|
|
|
‡a
Author's Acute and long-term effects of inhaled iloprost in portopulmonary hypertension
|
|
670
|
|
|
‡a
Author's [Adaptable and portable cephalometric devices: a new method in obtaining cephalometrics]
|
|
670
|
|
|
‡a
Author's Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses
|
|
670
|
|
|
‡a
Author's Adjustment of DLCO for hemoglobin concentration.
|
|
670
|
|
|
‡a
Author's Air pollution effects in the elderly: introduction.
|
|
670
|
|
|
‡a
Author's Algorithm for automatic forced spirometry quality assessment: technological developments
|
|
670
|
|
|
‡a
Author's An adaptive case management system to support integrated care services: Lessons learned from the NEXES project
|
|
670
|
|
|
‡a
Author's [An elevated prevalence of subclinical pulmonary involvement in systemic lupus erythematosus]
|
|
670
|
|
|
‡a
Author's An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's [Anatomical alterations of the upper airway in the sleeping apnea syndrome. Diagnostical and therapeutic implications]
|
|
670
|
|
|
‡a
Author's Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscle
|
|
670
|
|
|
‡a
Author's Another asthma outbreak in Barcelona: role of oxides of nitrogen
|
|
670
|
|
|
‡a
Author's Arterial oxygenation does not predict the outcome of patients with acute respiratory failure needing mechanical ventilation
|
|
670
|
|
|
‡a
Author's Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
|
|
670
|
|
|
‡a
Author's Assessment of health status and program performance in patients on long-term oxygen therapy
|
|
670
|
|
|
‡a
Author's Assessment of ventilation-perfusion mismatching in mechanically ventilated patients
|
|
670
|
|
|
‡a
Author's Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population
|
|
670
|
|
|
‡a
Author's Association study of proposed candidate genes/regions in a population of Spanish asthmatics
|
|
670
|
|
|
‡a
Author's Asthma outbreaks in Barcelona
|
|
670
|
|
|
‡a
Author's Automated spirometry quality assurance: supervised learning from multiple experts.
|
|
670
|
|
|
‡a
Author's Bacterial colonization as a potential source of nosocomial respiratory infections in two types of spirometer
|
|
670
|
|
|
‡a
Author's Below what FEV1 should arterial blood be routinely taken to detect chronic respiratory failure in COPD?
|
|
670
|
|
|
‡a
Author's Benefits of physical activity on COPD hospitalisation depend on intensity
|
|
670
|
|
|
‡a
Author's [Benign pleurisy caused by asbestos]
|
|
670
|
|
|
‡a
Author's Biomedical research in a Digital Health Framework
|
|
670
|
|
|
‡a
Author's Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia
|
|
670
|
|
|
‡a
Author's [Bronchial asthma and aerosol bronchodilators: incorrect use in our milieu]
|
|
670
|
|
|
‡a
Author's Bronchial reactivity in patients with chronic renal failure undergoing haemodialysis
|
|
670
|
|
|
‡a
Author's Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis
|
|
670
|
|
|
‡a
Author's Cellular bioenergetics after erythropoietin therapy in chronic renal failure.
|
|
670
|
|
|
‡a
Author's ChainRank, a chain prioritisation method for contextualisation of biological networks
|
|
670
|
|
|
‡a
Author's Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation
|
|
670
|
|
|
‡a
Author's Characteristics of patients with soybean dust-induced acute severe asthma requiring mechanical ventilation
|
|
670
|
|
|
‡a
Author's Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.
|
|
670
|
|
|
‡a
Author's Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD.
|
|
670
|
|
|
‡a
Author's Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management
|
|
670
|
|
|
‡a
Author's Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up
|
|
670
|
|
|
‡a
Author's Clinical and functional characteristics of patients two years after being affected by the soybean asthma epidemic in Barcelona
|
|
670
|
|
|
‡a
Author's Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Clinical decision support system to enhance quality control of spirometry using information and communication technologies
|
|
670
|
|
|
‡a
Author's Clinical Decision Support Systems (CDSS) for preventive management of COPD patients
|
|
670
|
|
|
‡a
Author's Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension
|
|
670
|
|
|
‡a
Author's Compartmentation of glycogen metabolism revealed from 13C isotopologue distributions
|
|
670
|
|
|
‡a
Author's Contribution of multiple inert gas elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique
|
|
670
|
|
|
‡a
Author's Contributions of multiple inert gas elimination technique to pulmonary medicine.3. Bronchial asthma
|
|
670
|
|
|
‡a
Author's COPD exacerbations: who is safe to be managed at home
|
|
670
|
|
|
‡a
Author's Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis
|
|
670
|
|
|
‡a
Author's Cryptic haplotypes ofSERPINA1confer susceptibility to chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Cured meat consumption increases risk of readmission in COPD patients
|
|
670
|
|
|
‡a
Author's Determinants of exercise capacity in obese and non-obese COPD patients
|
|
670
|
|
|
‡a
Author's [Determination of the distribution of ventilation-perfusion ratios: technic of elimination of multiple inert gases]
|
|
670
|
|
|
‡a
Author's Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis
|
|
670
|
|
|
‡a
Author's Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs
|
|
670
|
|
|
‡a
Author's Dissociation of maximal O2 uptake from O2 delivery in canine gastrocnemius in situ
|
|
670
|
|
|
‡a
Author's Does oxidative stress modulate limb muscle atrophy in severe COPD patients?
|
|
670
|
|
|
‡a
Author's Early lung function changes after short heavy exposure to chrysotile asbestos in non-smoking women
|
|
670
|
|
|
‡a
Author's Echocardiographic abnormalities in patients with COPD at their first hospital admission
|
|
670
|
|
|
‡a
Author's Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
|
|
670
|
|
|
‡a
Author's Effect of Acetylsalicylic Acid on Pulmonary Gas Exchange in Patients With Severe Pneumonia
|
|
670
|
|
|
‡a
Author's Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome
|
|
670
|
|
|
‡a
Author's Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.
|
|
670
|
|
|
‡a
Author's Effect of Inverse I
|
|
670
|
|
|
‡a
Author's Effect of nifedipine on arterial hypoxaemia occurring after methacholine challenge in asthma.
|
|
670
|
|
|
‡a
Author's Effect of nitric oxide inhalation on gas exchange in acute severe pneumonia
|
|
670
|
|
|
‡a
Author's Effect of nitric oxide inhalation on respiratory system resistance in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma.
|
|
670
|
|
|
‡a
Author's Effect of sampling site on femoral venous blood gas values
|
|
670
|
|
|
‡a
Author's Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial
|
|
670
|
|
|
‡a
Author's Effects and barriers to deployment of telehealth wellness programs for chronic patients across 3 European countries
|
|
670
|
|
|
‡a
Author's Effects of altitude acclimatization on pulmonary gas exchange during exercise
|
|
670
|
|
|
‡a
Author's Effects of an integrated care intervention on risk factors of COPD readmission
|
|
670
|
|
|
‡a
Author's Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.
|
|
670
|
|
|
‡a
Author's Effects of FIO2 on leg ??VO2 during cycle ergometry in sedentary subjects
|
|
670
|
|
|
‡a
Author's Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma
|
|
670
|
|
|
‡a
Author's Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis
|
|
670
|
|
|
‡a
Author's Effects of interval and continuous exercise training on autonomic cardiac function in COPD patients
|
|
670
|
|
|
‡a
Author's Effects of lung ventilation-perfusion and muscle metabolism-perfusion heterogeneities on maximal O2 transport and utilization
|
|
670
|
|
|
‡a
Author's Effects of nebulized N
|
|
670
|
|
|
‡a
Author's Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome
|
|
670
|
|
|
‡a
Author's Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Effects of PEEP on VA/Q mismatching in ventilated patients with chronic airflow obstruction
|
|
670
|
|
|
‡a
Author's Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis
|
|
670
|
|
|
‡a
Author's Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients
|
|
670
|
|
|
‡a
Author's Endothelial dysfunction in pulmonary arteries of patients with mild COPD
|
|
670
|
|
|
‡a
Author's Endurance exercise training improves heart rate recovery in patients with COPD.
|
|
670
|
|
|
‡a
Author's Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing
|
|
670
|
|
|
‡a
Author's Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
|
|
670
|
|
|
‡a
Author's Estudio del gen BMPR2 en pacientes con hipertensión arterial pulmonar
|
|
670
|
|
|
‡a
Author's [Evaluation exercise tolerance in COPD patients: the 6-minute walking test]
|
|
670
|
|
|
‡a
Author's Evaluation of a method for assessing respiratory mechanics during noninvasive ventilation.
|
|
670
|
|
|
‡a
Author's [Evaluation of the cephalometric structure of the upper airway on the configuration of the obstructive sleep apnea syndrome]
|
|
670
|
|
|
‡a
Author's Evidence for tissue diffusion limitation of VO2max in normal humans
|
|
670
|
|
|
‡a
Author's Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps
|
|
670
|
|
|
‡a
Author's Expression of BK
|
|
670
|
|
|
‡a
Author's Expression of BK(Ca) channels in human pulmonary arteries: relationship with remodeling and hypoxic pulmonary vasoconstriction
|
|
670
|
|
|
‡a
Author's Fatal airway disease in an adult with chronic graft-versus-host disease
|
|
670
|
|
|
‡a
Author's Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
|
|
670
|
|
|
‡a
Author's Formoterol protects against platelet-activating factor-induced effects in asthma
|
|
670
|
|
|
‡a
Author's From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration
|
|
670
|
|
|
‡a
Author's From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
|
|
670
|
|
|
‡a
Author's Gas compression artefacts when testing peak expiratory flow meters with mechanically-driven syringes
|
|
670
|
|
|
‡a
Author's Gas exchange and pulmonary hemodynamics during lung resection in patients at increased risk: relationship with preoperative exercise testing
|
|
670
|
|
|
‡a
Author's Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis.
|
|
670
|
|
|
‡a
Author's Gas exchange during exercise in mild chronic obstructive pulmonary disease. Correlation with lung structure
|
|
670
|
|
|
‡a
Author's Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome
|
|
670
|
|
|
‡a
Author's Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study
|
|
670
|
|
|
‡a
Author's Gas exchange response to intravenous aminophylline in patients with a severe exacerbation of asthma
|
|
670
|
|
|
‡a
Author's Gas exchange response to naloxone in chronic obstructive pulmonary disease with hypercapnic respiratory failure
|
|
670
|
|
|
‡a
Author's Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations
|
|
670
|
|
|
‡a
Author's Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.
|
|
670
|
|
|
‡a
Author's Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations
|
|
670
|
|
|
‡a
Author's Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation
|
|
670
|
|
|
‡a
Author's Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology
|
|
670
|
|
|
‡a
Author's Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Health Outcomes from Home Hospitalization: Multisource Predictive Modeling
|
|
670
|
|
|
‡a
Author's Heart Rate Recovery After 6-min Walking Test Predicts Acute Exacerbation in COPD.
|
|
670
|
|
|
‡a
Author's Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension
|
|
670
|
|
|
‡a
Author's Hepatopulmonary syndrome associated with cardiorespiratory disease
|
|
670
|
|
|
‡a
Author's Hepatopulmonary syndrome in candidates for liver transplantation
|
|
670
|
|
|
‡a
Author's Hepatopulmonary syndrome: the paradigm of liver-induced hypoxaemia
|
|
670
|
|
|
‡a
Author's HLA Class II Genes in Soybean Epidemic Asthma Patients
|
|
670
|
|
|
‡a
Author's HLA Distribution in COPD Patients
|
|
670
|
|
|
‡a
Author's Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
|
|
670
|
|
|
‡a
Author's Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
|
|
670
|
|
|
‡a
Author's Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Impaired muscle oxygen transfer in patients with chronic renal failure
|
|
670
|
|
|
‡a
Author's Importance of mitochondrial P
|
|
670
|
|
|
‡a
Author's Importance of mitochondrial P(O2) in maximal O2 transport and utilization: a theoretical analysis
|
|
670
|
|
|
‡a
Author's Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals
|
|
670
|
|
|
‡a
Author's Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients
|
|
670
|
|
|
‡a
Author's Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Inhaled platelet-activating factor worsens gas exchange in mild asthma.
|
|
670
|
|
|
‡a
Author's Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation
|
|
670
|
|
|
‡a
Author's Instrumental drift removal in GC-MS data for breath analysis: the short-term and long-term temporal validation of putative biomarkers for COPD.
|
|
670
|
|
|
‡a
Author's Integrated Care Intervention Supported by a Mobile Health Tool for Patients Using Noninvasive Ventilation at Home: Randomized Controlled Trial
|
|
670
|
|
|
‡a
Author's Integrated care pathways for airway diseases
|
|
670
|
|
|
‡a
Author's Integrated care pathways for airway diseases (AIRWAYS-ICPs).
|
|
670
|
|
|
‡a
Author's Integrated care prevents hospitalisations for exacerbations in COPD patients
|
|
670
|
|
|
‡a
Author's Integrated care services: lessons learned from the deployment of the NEXES project
|
|
670
|
|
|
‡a
Author's Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis.
|
|
670
|
|
|
‡a
Author's Interplay of intrapulmonary and extrapulmonary factors on pulmonary gas exchange during weaning
|
|
670
|
|
|
‡a
Author's Invasive exercise testing in the evaluation of patients at high-risk for lung resection
|
|
670
|
|
|
‡a
Author's Is it necessary to treat all patients with idiopathic pulmonary fibrosis?
|
|
670
|
|
|
‡a
Author's Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension
|
|
670
|
|
|
‡a
Author's Knowledge management for systems biology a general and visually driven framework applied to translational medicine
|
|
670
|
|
|
‡a
Author's La heterogeneidad fenotípica de la EPOC
|
|
670
|
|
|
‡a
Author's Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor
|
|
670
|
|
|
‡a
Author's Limitation of maximal O2 uptake and performance by acute hypoxia in dog muscle in situ
|
|
670
|
|
|
‡a
Author's Lung function changes following Legionnaires' disease
|
|
670
|
|
|
‡a
Author's Lung function in allogeneic bone marrow transplantation recipients
|
|
670
|
|
|
‡a
Author's Lung structure and gas exchange in mild chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Measurement of exhaled nitric oxide in healthy subjects
|
|
670
|
|
|
‡a
Author's Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths
|
|
670
|
|
|
‡a
Author's Mechanisms of Abnormal Gas Exchange in Patients with Pneumonia
|
|
670
|
|
|
‡a
Author's Mechanisms of gas exchange impairment in patients with liver cirrhosis
|
|
670
|
|
|
‡a
Author's Mechanisms of gas exchange response to lung volume reduction surgery in severe emphysema
|
|
670
|
|
|
‡a
Author's Mechanisms of hypoxemia
|
|
670
|
|
|
‡a
Author's Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation
|
|
670
|
|
|
‡a
Author's Mechanisms of pulmonary gas exchange improvement during a protective ventilatory strategy in acute respiratory distress syndrome
|
|
670
|
|
|
‡a
Author's Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Modeling of spatial metabolite distributions in the cardiac sarcomere
|
|
670
|
|
|
‡a
Author's Molecular mechanisms underlying COPD-muscle dysfunction unveiled through a systems medicine approach.
|
|
670
|
|
|
‡a
Author's Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population
|
|
670
|
|
|
‡a
Author's Muscle and blood redox status after exercise training in severe COPD patients
|
|
670
|
|
|
‡a
Author's Muscle angiogenic growth factor gene responses to exercise in chronic renal failure
|
|
670
|
|
|
‡a
Author's Nebulized Glutathione Induces Bronchoconstriction in Patients with Mild Asthma
|
|
670
|
|
|
‡a
Author's Network medicine analysis of COPD multimorbidities
|
|
670
|
|
|
‡a
Author's New design for fixation of surgically obtained lung specimens.
|
|
670
|
|
|
‡a
Author's New solutions for personalised health management: citizens' needs, healthcare changes, and market perspectives round table debate
|
|
670
|
|
|
‡a
Author's Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD.
|
|
670
|
|
|
‡a
Author's Noninvasive assessment of respiratory resistance in severe chronic respiratory patients with nasal CPAP
|
|
670
|
|
|
‡a
Author's Nordic walking enhances oxygen uptake without increasing the rate of perceived exertion in patients with chronic obstructive pulmonary disease.
|
|
670
|
|
|
‡a
Author's Occupational asthma in the community: risk factors in a western Mediterranean population
|
|
670
|
|
|
‡a
Author's Optimized pacing mode for hypertrophic cardiomyopathy: Impact of ECG fusion during pacing.
|
|
670
|
|
|
‡a
Author's Oscillatory resistance measured during noninvasive proportional assist ventilation.
|
|
670
|
|
|
‡a
Author's Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
|
|
670
|
|
|
‡a
Author's Oxygen: from the atmosphere to mitochondria
|
|
670
|
|
|
‡a
Author's Oxygen pathway modeling estimates high reactive oxygen species production above the highest permanent human habitation
|
|
670
|
|
|
‡a
Author's Oxyhemoglobin affinity in patients with chronic obstructive pulmonary disease and acute respiratory failure
|
|
670
|
|
|
‡a
Author's Pathophysiology of muscle dysfunction in COPD.
|
|
670
|
|
|
‡a
Author's Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension
|
|
670
|
|
|
‡a
Author's Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial
|
|
670
|
|
|
‡a
Author's Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014
|
|
670
|
|
|
‡a
Author's Physical activity and clinical and functional status in COPD.
|
|
670
|
|
|
‡a
Author's Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension
|
|
670
|
|
|
‡a
Author's Physiological changes in respiratory function associated with ageing
|
|
670
|
|
|
‡a
Author's Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Platelet-activating factor causes ventilation-perfusion mismatch in humans
|
|
670
|
|
|
‡a
Author's Pneumocystis pneumonia in HIV antibody positive patients
|
|
670
|
|
|
‡a
Author's Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey.
|
|
670
|
|
|
‡a
Author's Prediction equations for plethysmographic lung volumes.
|
|
670
|
|
|
‡a
Author's Predictive medicine: outcomes, challenges and opportunities in the Synergy-COPD project
|
|
670
|
|
|
‡a
Author's Proposals for enhanced health risk assessment and stratification in an integrated care scenario
|
|
670
|
|
|
‡a
Author's Protocol for regional implementation of collaborative lung function testing
|
|
670
|
|
|
‡a
Author's Protocol for regional implementation of community-based collaborative management of complex chronic patients
|
|
670
|
|
|
‡a
Author's Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange in severe chronic asthma. Response to 100% oxygen and salbutamol
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma
|
|
670
|
|
|
‡a
Author's Pulmonary Gas Exchange Response to Oxygen Breathing in Acute Lung Injury
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange response to weaning with pressure-support ventilation in exacerbated chronic obstructive pulmonary disease patients
|
|
670
|
|
|
‡a
Author's Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma
|
|
670
|
|
|
‡a
Author's Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
|
|
670
|
|
|
‡a
Author's Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis.
|
|
670
|
|
|
‡a
Author's Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.
|
|
670
|
|
|
‡a
Author's Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Spanish Group of the European Community Respiratory Health Survey
|
|
670
|
|
|
‡a
Author's Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
|
|
670
|
|
|
‡a
Author's Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain
|
|
670
|
|
|
‡a
Author's [Read me, please!]
|
|
670
|
|
|
‡a
Author's Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers
|
|
670
|
|
|
‡a
Author's Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's References values for forced spirometry. Group of the European Community Respiratory Health Survey.
|
|
670
|
|
|
‡a
Author's Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study
|
|
670
|
|
|
‡a
Author's Relationship between serum IgE and airway responsiveness in adults with asthma
|
|
670
|
|
|
‡a
Author's [Respiratory response to chemical stimuli and exercise capacity under conditions of acute hypoxia in elite mountain climbers]
|
|
670
|
|
|
‡a
Author's Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
|
|
670
|
|
|
‡a
Author's Safety of Parecoxib in Asthmatic Patients with Aspirin-Exacerbated Respiratory Disease
|
|
670
|
|
|
‡a
Author's Salbutamol inhibits pulmonary effects of platelet activating factor in man.
|
|
670
|
|
|
‡a
Author's Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans
|
|
670
|
|
|
‡a
Author's Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
|
|
670
|
|
|
‡a
Author's Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization
|
|
670
|
|
|
‡a
Author's Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
|
|
670
|
|
|
‡a
Author's Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.
|
|
670
|
|
|
‡a
Author's Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.
|
|
670
|
|
|
‡a
Author's Spirometric response to a bronchodilator. Reference values for healthy children and adolescents
|
|
670
|
|
|
‡a
Author's [Standardization of the measurement of transfer factor
|
|
670
|
|
|
‡a
Author's [Standardization of the measurement of transfer factor (diffusing capacity). Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]
|
|
670
|
|
|
‡a
Author's [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
|
|
670
|
|
|
‡a
Author's [Subclinical changes produced by prolonged treatment with amiodarone]
|
|
670
|
|
|
‡a
Author's Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.
|
|
670
|
|
|
‡a
Author's Sustained ventricular tachycardia as a marker of inadequate myocardial perfusion during the acute phase of myocardial infarction
|
|
670
|
|
|
‡a
Author's [Symbols, abbreviations and units. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]
|
|
670
|
|
|
‡a
Author's Synergy-COPD: a systems approach for understanding and managing chronic diseases
|
|
670
|
|
|
‡a
Author's Systemic effects of cigarette smoke exposure in the guinea pig.
|
|
670
|
|
|
‡a
Author's Systems medicine and integrated care to combat chronic noncommunicable diseases
|
|
670
|
|
|
‡a
Author's Systems Medicine: from molecular features and models to the clinic in COPD.
|
|
670
|
|
|
‡a
Author's Telemedicine-based approach for obstructive sleep apnea management: building evidence.
|
|
670
|
|
|
‡a
Author's Telemedicine enhances quality of forced spirometry in primary care
|
|
670
|
|
|
‡a
Author's Telemedicine experience for chronic care in COPD.
|
|
670
|
|
|
‡a
Author's Testing the Measurement Properties of the Spanish Version of the SF-36 Health Survey Among Male Patients with Chronic Obstructive Pulmonary Disease
|
|
670
|
|
|
‡a
Author's The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital
|
|
670
|
|
|
‡a
Author's The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research
|
|
670
|
|
|
‡a
Author's The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma
|
|
670
|
|
|
‡a
Author's The impact of home hospitalization on healthcare costs of exacerbations in COPD patients
|
|
670
|
|
|
‡a
Author's The lung in patients with cirrhosis
|
|
670
|
|
|
‡a
Author's The role of external and matrix pH in mitochondrial reactive oxygen species generation
|
|
670
|
|
|
‡a
Author's The role of peripheral muscles on exercise tolerance in patients with COPD
|
|
670
|
|
|
‡a
Author's The SERPINE2 gene and chronic obstructive pulmonary disease.
|
|
670
|
|
|
‡a
Author's Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma
|
|
670
|
|
|
‡a
Author's Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index
|
|
670
|
|
|
‡a
Author's Unsupervised self-testing of airway obstruction by forced oscillation at the patient's home
|
|
670
|
|
|
‡a
Author's Update '96 on pulmonary gas exchange pathophysiology in pneumonia.
|
|
670
|
|
|
‡a
Author's [Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy]
|
|
670
|
|
|
‡a
Author's Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients
|
|
670
|
|
|
‡a
Author's Value of chest radiography in phenotyping chronic obstructive pulmonary disease.
|
|
670
|
|
|
‡a
Author's Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
|
|
670
|
|
|
‡a
Author's Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity
|
|
670
|
|
|
‡a
Author's Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma
|
|
670
|
|
|
‡a
Author's Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis
|
|
670
|
|
|
‡a
Author's Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning
|
|
670
|
|
|
‡a
Author's Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD
|
|
670
|
|
|
‡a
Author's Ventilatory control in diabetes mellitus
|
|
670
|
|
|
‡a
Author's Workforce preparation: the Biohealth computing model for Master and PhD students
|
|
670
|
|
|
‡a
Author's Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1108556426
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 2017036745
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000030171653
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNE|XX5136844
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNE|XX904756
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/6159916
|
|
909
|
|
|
‡a
(orcid) 0000000347688722
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7101624354
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000246508542
‡9
1
|
|
912
|
|
|
‡a
integratedcarepathwaysforairwaydiseases
‡A
Integrated care pathways for airway diseases
‡9
1
|
|
912
|
|
|
‡a
scalingupstrategiesofthechronicrespiratorydiseaseprogrammeoftheeuropeaninnovationpartnershiponactiveandhealthyageingactionplanb3area5
‡A
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
‡9
1
|
|
912
|
|
|
‡a
integratedcarepathwaysforairwaydiseasesairwaysicps
‡A
Integrated care pathways for airway diseases (AIRWAYS-ICPs).
‡9
1
|
|
912
|
|
|
‡a
erratumtoscalingupstrategiesofthechronicrespiratorydiseaseprogrammeoftheeuropeaninnovationpartnershiponactiveandhealthyageing
‡A
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing
‡9
1
|
|
912
|
|
|
‡a
erratumtoscalingupstrategiesofthechronicrespiratorydiseaseprogrammeoftheeuropeaninnovationpartnershiponactiveandhealthyageingactionplanb3area5
‡A
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
‡9
1
|
|
919
|
|
|
‡a
sildenafiltoimproverespiratoryrehabilitationoutcomesincopdacontrolledtrial
‡A
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
‡9
1
|
|
919
|
|
|
‡a
heterogeneidadfenotipicadelaepoc
‡A
La heterogeneidad fenotípica de la EPOC
‡9
1
|
|
919
|
|
|
‡a
variationinthetumournecrosisfactorgeneisnotassociatedwithsusceptibilitytocopd
‡A
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
‡9
1
|
|
919
|
|
|
‡a
knowledgemanagementforsystemsbiologyageneralandvisuallydrivenframeworkappliedtotranslationalmedicine
‡A
Knowledge management for systems biology a general and visually driven framework applied to translational medicine
‡9
1
|
|
919
|
|
|
‡a
inhibitionofpafinducedgasexchangedefectsbybetaadrenergicagonistsinmildasthmaisnotduetobronchodilation
‡A
Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation
‡9
1
|
|
919
|
|
|
‡a
chronicobstructivepulmonarydiseaseheterogeneitychallengesforhealthriskassessmentstratificationandmanagement
‡A
Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management
‡9
1
|
|
919
|
|
|
‡a
assessmentofhealthstatusandprogramperformanceinpatientsonlongtermoxygentherapy
‡A
Assessment of health status and program performance in patients on long-term oxygen therapy
‡9
1
|
|
919
|
|
|
‡a
instrumentaldriftremovalingcmsdataforbreathanalysistheshorttermandlongtermtemporalvalidationofputativebiomarkersforcopd
‡A
Instrumental drift removal in GC-MS data for breath analysis: the short-term and long-term temporal validation of putative biomarkers for COPD.
‡9
1
|
|
919
|
|
|
‡a
mechanismsofpulmonarygasexchangeimprovementduringaprotectiveventilatorystrategyinacuterespiratorydistresssyndrome
‡A
Mechanisms of pulmonary gas exchange improvement during a protective ventilatory strategy in acute respiratory distress syndrome
‡9
1
|
|
919
|
|
|
‡a
integratedcareinterventionsupportedbyamobilehealthtoolforpatientsusingnoninvasiveventilationathomerandomizedcontrolledtrial
‡A
Integrated Care Intervention Supported by a Mobile Health Tool for Patients Using Noninvasive Ventilation at Home: Randomized Controlled Trial
‡9
1
|
|
919
|
|
|
‡a
mechanismsofgasexchangeimpairmentinpatientswithlivercirrhosis
‡A
Mechanisms of gas exchange impairment in patients with liver cirrhosis
‡9
1
|
|
919
|
|
|
‡a
effectofinverse1
‡A
Effect of Inverse I
‡9
1
|
|
919
|
|
|
‡a
mechanismsofabnormalgasexchangeinpatientswithpneumonia
‡A
Mechanisms of Abnormal Gas Exchange in Patients with Pneumonia
‡9
1
|
|
919
|
|
|
‡a
valueofchestradiographyinphenotypingchronicobstructivepulmonarydisease
‡A
Value of chest radiography in phenotyping chronic obstructive pulmonary disease.
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeresponsetoweaningwithpressuresupportventilationinexacerbatedchronicobstructivepulmonarydiseasepatients
‡A
Pulmonary gas exchange response to weaning with pressure-support ventilation in exacerbated chronic obstructive pulmonary disease patients
‡9
1
|
|
919
|
|
|
‡a
hypoxicpulmonaryvasoconstrictionandgasexchangeduringexerciseinchronicobstructivepulmonarydisease
‡A
Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
serpine2geneandchronicobstructivepulmonarydisease
‡A
The SERPINE2 gene and chronic obstructive pulmonary disease.
‡9
1
|
|
919
|
|
|
‡a
expressionofbk
‡A
Expression of BK
‡9
1
|
|
919
|
|
|
‡a
totalserumigeisassociatedwithasthmaindependentlyofspecificigelevelsthespanishgroupoftheeuropeanstudyofasthma
‡A
Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma
‡9
1
|
|
919
|
|
|
‡a
trainingdepletesmuscleglutathioneinpatientswithchronicobstructivepulmonarydiseaseandlowbodymassindex
‡A
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index
‡9
1
|
|
919
|
|
|
‡a
evidenceofo2supplydependentvo2maxintheexercisetrainedhumanquadriceps
‡A
Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps
‡9
1
|
|
919
|
|
|
‡a
effectsofpropranololonarterialoxygenationandoxygentransporttotissuesinpatientswithcirrhosis
‡A
Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis
‡9
1
|
|
919
|
|
|
‡a
telemedicineenhancesqualityofforcedspirometryinprimarycare
‡A
Telemedicine enhances quality of forced spirometry in primary care
‡9
1
|
|
919
|
|
|
‡a
lungstructureandgasexchangeinmildchronicobstructivepulmonarydisease
‡A
Lung structure and gas exchange in mild chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
anatomicalalterationsoftheupperairwayinthesleepingapneasyndromediagnosticalandtherapeuticimplications
‡A
[Anatomical alterations of the upper airway in the sleeping apnea syndrome. Diagnostical and therapeutic implications]
‡9
1
|
|
919
|
|
|
‡a
digitalhealthtransformationofintegratedcareineuropeoverarchinganalysisof17integratedcareprograms
‡A
Digital Health Transformation of Integrated Care in Europe: Overarching Analysis of 17 Integrated Care Programs
‡9
1
|
|
919
|
|
|
‡a
evidencefortissuediffusionlimitationofvo2maxinnormalhumans
‡A
Evidence for tissue diffusion limitation of VO2max in normal humans
‡9
1
|
|
919
|
|
|
‡a
encouraged6minwalkingtestindicatesmaximumsustainableexerciseincopdpatients
‡A
Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients
‡9
1
|
|
919
|
|
|
‡a
evaluationofthecephalometricstructureoftheupperairwayontheconfigurationoftheobstructivesleepapneasyndrome
‡A
[Evaluation of the cephalometric structure of the upper airway on the configuration of the obstructive sleep apnea syndrome]
‡9
1
|
|
919
|
|
|
‡a
clinicalassessmentofperipheralmusclefunctioninpatientswithchronicobstructivepulmonarydisease
‡A
Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
mechanismsofhypoxemiainpatientswithstatusasthmaticusrequiringmechanicalventilation
‡A
Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation
‡9
1
|
|
919
|
|
|
‡a
adenosine5monophosphateinasthmagasexchangeandsputumcellularresponses
‡A
Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses
‡9
1
|
|
919
|
|
|
‡a
pulmonaryhemodynamicprofileinchronicobstructivepulmonarydisease
‡A
Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
‡9
1
|
|
919
|
|
|
‡a
telemedicineexperienceforchroniccareincopd
‡A
Telemedicine experience for chronic care in COPD.
‡9
1
|
|
919
|
|
|
‡a
modelingofspatialmetabolitedistributionsinthecardiacsarcomere
‡A
Modeling of spatial metabolite distributions in the cardiac sarcomere
‡9
1
|
|
919
|
|
|
‡a
effectofnifedipineonarterialhypoxaemiaoccurringaftermethacholinechallengeinasthma
‡A
Effect of nifedipine on arterial hypoxaemia occurring after methacholine challenge in asthma.
‡9
1
|
|
919
|
|
|
‡a
chronicenduranceexerciseinducesquadricepsnitrosativestressinpatientswithseverecopd
‡A
Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD.
‡9
1
|
|
919
|
|
|
‡a
unsupervisedselftestingofairwayobstructionbyforcedoscillationatthepatientshome
‡A
Unsupervised self-testing of airway obstruction by forced oscillation at the patient's home
‡9
1
|
|
919
|
|
|
‡a
assessmentofacutepulmonaryvascularreactivityinportopulmonaryhypertension
‡A
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
‡9
1
|
|
919
|
|
|
‡a
validationoftheyalephysicalactivitysurveyinchronicobstructivepulmonarydiseasepatients
‡A
Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients
‡9
1
|
|
919
|
|
|
‡a
arterialoxygenationdoesnotpredicttheoutcomeofpatientswithacuterespiratoryfailureneedingmechanicalventilation
‡A
Arterial oxygenation does not predict the outcome of patients with acute respiratory failure needing mechanical ventilation
‡9
1
|
|
919
|
|
|
‡a
effectofnitricoxidesynthesisinhibitionwithnebulized50nameonventilationperfusiondistributionsinbronchialasthma
‡A
Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma.
‡9
1
|
|
919
|
|
|
‡a
effectsofinhaledfurosemideonplateletactivatingfactorchallengeinmildasthma
‡A
Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma
‡9
1
|
|
919
|
|
|
‡a
muscleandbloodredoxstatusafterexercisetraininginseverecopdpatients
‡A
Muscle and blood redox status after exercise training in severe COPD patients
‡9
1
|
|
919
|
|
|
‡a
oxidativestressredoxsignalingpathwaysandautophagyincachecticmusclesofmalepatientswithadvancedcopdandlungcancer
‡A
Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
‡9
1
|
|
919
|
|
|
‡a
ventilationperfusionmismatchaftermethacholinechallengeinpatientswithmildbronchialasthma
‡A
Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma
‡9
1
|
|
919
|
|
|
‡a
evaluationofamethodforassessingrespiratorymechanicsduringnoninvasiveventilation
‡A
Evaluation of a method for assessing respiratory mechanics during noninvasive ventilation.
‡9
1
|
|
919
|
|
|
‡a
sustainedlowdiffusingcapacityinhepatopulmonarysyndromeafterlivertransplantation
‡A
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.
‡9
1
|
|
919
|
|
|
‡a
mechanicalventilationinsevereexacerbationofasthmastudyof26caseswith6deaths
‡A
Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths
‡9
1
|
|
919
|
|
|
‡a
subclinicalchangesproducedbyprolongedtreatmentwithamiodarone
‡A
[Subclinical changes produced by prolonged treatment with amiodarone]
‡9
1
|
|
919
|
|
|
‡a
measurementofexhalednitricoxideinhealthysubjects
‡A
Measurement of exhaled nitric oxide in healthy subjects
‡9
1
|
|
919
|
|
|
‡a
relationsbetweenrespiratorysymptomsandspirometricvaluesinyoungadultstheeuropeancommunityrespiratoryhealthstudy
‡A
Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study
‡9
1
|
|
919
|
|
|
‡a
effectofsamplingsiteonfemoralvenousbloodgasvalues
‡A
Effect of sampling site on femoral venous blood gas values
‡9
1
|
|
919
|
|
|
‡a
homehospitalisationofexacerbatedchronicobstructivepulmonarydiseasepatients
‡A
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
‡9
1
|
|
919
|
|
|
‡a
asthmaoutbreaksinbarcelona
‡A
Asthma outbreaks in Barcelona
‡9
1
|
|
919
|
|
|
‡a
associationstudyofproposedcandidategenesregionsinapopulationofspanishasthmatics
‡A
Association study of proposed candidate genes/regions in a population of Spanish asthmatics
‡9
1
|
|
919
|
|
|
‡a
multimorbidityasapredictorofhealthserviceutilizationinprimarycarearegistrybasedstudyofthecatalanpopulation
‡A
Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population
‡9
1
|
|
919
|
|
|
‡a
hladistributionincopdpatients
‡A
HLA Distribution in COPD Patients
‡9
1
|
|
919
|
|
|
‡a
newdesignforfixationofsurgicallyobtainedlungspecimens
‡A
New design for fixation of surgically obtained lung specimens.
‡9
1
|
|
919
|
|
|
‡a
molecularmechanismsunderlyingcopdmuscledysfunctionunveiledthroughasystemsmedicineapproach
‡A
Molecular mechanisms underlying COPD-muscle dysfunction unveiled through a systems medicine approach.
‡9
1
|
|
919
|
|
|
‡a
isitnecessarytotreatallpatientswithidiopathicpulmonaryfibrosis
‡A
Is it necessary to treat all patients with idiopathic pulmonary fibrosis?
‡9
1
|
|
919
|
|
|
‡a
invasiveexercisetestingintheevaluationofpatientsathighriskforlungresection
‡A
Invasive exercise testing in the evaluation of patients at high-risk for lung resection
‡9
1
|
|
919
|
|
|
‡a
relationshipbetweenserumigeandairwayresponsivenessinadultswithasthma
‡A
Relationship between serum IgE and airway responsiveness in adults with asthma
‡9
1
|
|
919
|
|
|
‡a
skeletalmusclemitochondrialfunctionispreservedinyoungpatientswithchronicrenalfailure
‡A
Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.
‡9
1
|
|
919
|
|
|
‡a
nonanaemicirondeficiencyimpairsresponsetopulmonaryrehabilitationincopd
‡A
Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD.
‡9
1
|
|
919
|
|
|
‡a
bronchialreactivityinpatientswithchronicrenalfailureundergoinghaemodialysis
‡A
Bronchial reactivity in patients with chronic renal failure undergoing haemodialysis
‡9
1
|
|
919
|
|
|
‡a
effectofbronchialcolonisationonairwayandsystemicinflammationinstablecopd
‡A
Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.
‡9
1
|
|
919
|
|
|
‡a
leukotriened4inducedhypoxaemiainasthmaismediatedbythecysleukotriene1receptor
‡A
Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor
‡9
1
|
|
919
|
|
|
‡a
singlebreathcarbonmonoxidediffusingcapacitypredictionequationsfromamediterraneanpopulation
‡A
Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.
‡9
1
|
|
919
|
|
|
‡a
hlaclass2genesinsoybeanepidemicasthmapatients
‡A
HLA Class II Genes in Soybean Epidemic Asthma Patients
‡9
1
|
|
919
|
|
|
‡a
gasexchangeresponsetonaloxoneinchronicobstructivepulmonarydiseasewithhypercapnicrespiratoryfailure
‡A
Gas exchange response to naloxone in chronic obstructive pulmonary disease with hypercapnic respiratory failure
‡9
1
|
|
919
|
|
|
‡a
ventilationperfusionmismatchinpatientswithpleuraleffusioneffectsofthoracentesis
‡A
Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis
‡9
1
|
|
919
|
|
|
‡a
hepatopulmonarysyndrometheparadigmofliverinducedhypoxaemia
‡A
Hepatopulmonary syndrome: the paradigm of liver-induced hypoxaemia
‡9
1
|
|
919
|
|
|
‡a
ventilationperfusionmismatchinginchronicobstructivepulmonarydiseaseduringventilatorweaning
‡A
Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning
‡9
1
|
|
919
|
|
|
‡a
hepatopulmonarysyndromeincandidatesforlivertransplantation
‡A
Hepatopulmonary syndrome in candidates for liver transplantation
‡9
1
|
|
919
|
|
|
‡a
hepatopulmonarysyndromeassociatedwithcardiorespiratorydisease
‡A
Hepatopulmonary syndrome associated with cardiorespiratory disease
‡9
1
|
|
919
|
|
|
‡a
occupationalasthmainthecommunityriskfactorsinawesternmediterraneanpopulation
‡A
Occupational asthma in the community: risk factors in a western Mediterranean population
‡9
1
|
|
919
|
|
|
‡a
hemodynamicandgasexchangeeffectsofsildenafilinpatientswithchronicobstructivepulmonarydiseaseandpulmonaryhypertension
‡A
Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension
‡9
1
|
|
919
|
|
|
‡a
usefulnessofalungcancerrapiddiagnosisspecialistcliniccontributionofultrasoundbronchoscopy
‡A
[Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy]
‡9
1
|
|
919
|
|
|
‡a
heartraterecoveryafter6minwalkingtestpredictsacuteexacerbationincopd
‡A
Heart Rate Recovery After 6-min Walking Test Predicts Acute Exacerbation in COPD.
‡9
1
|
|
919
|
|
|
‡a
bronchoalveolarlavagecellularanalysisandgalliumlungscanintheassessmentofpatientswithamiodaroneinducedpneumonitis
‡A
Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis
‡9
1
|
|
919
|
|
|
‡a
effectsofpeeponvaqmismatchinginventilatedpatientswithchronicairflowobstruction
‡A
Effects of PEEP on VA/Q mismatching in ventilated patients with chronic airflow obstruction
‡9
1
|
|
919
|
|
|
‡a
healthoutcomesfromhomehospitalizationmultisourcepredictivemodeling
‡A
Health Outcomes from Home Hospitalization: Multisource Predictive Modeling
‡9
1
|
|
919
|
|
|
‡a
evaluationexercisetoleranceincopdpatientsthe6minutewalkingtest
‡A
[Evaluation exercise tolerance in COPD patients: the 6-minute walking test]
‡9
1
|
|
919
|
|
|
‡a
ventilationperfusionresponseafterfenoterolinhypoxemicpatientswithstablecopd
‡A
Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeresponsetooxygenbreathinginacutelunginjury
‡A
Pulmonary Gas Exchange Response to Oxygen Breathing in Acute Lung Injury
‡9
1
|
|
919
|
|
|
‡a
guidelinesfortheevaluationandtreatmentofmuscledysfunctioninpatientswithchronicobstructivepulmonarydisease
‡A
Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
nitricoxideinhalationduringexerciseinchronicobstructivepulmonarydisease
‡A
Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
identificationandprospectivevalidationofclinicallyrelevantchronicobstructivepulmonarydisease
‡A
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
gascompressionartefactswhentestingpeakexpiratoryflowmeterswithmechanicallydrivensyringes
‡A
Gas compression artefacts when testing peak expiratory flow meters with mechanically-driven syringes
‡9
1
|
|
919
|
|
|
‡a
nordicwalkingenhancesoxygenuptakewithoutincreasingtherateofperceivedexertioninpatientswithchronicobstructivepulmonarydisease
‡A
Nordic walking enhances oxygen uptake without increasing the rate of perceived exertion in patients with chronic obstructive pulmonary disease.
‡9
1
|
|
919
|
|
|
‡a
effectsofnebulizedngnitro50argininemethylesterinpatientswithhepatopulmonarysyndrome
‡A
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome
‡9
1
|
|
919
|
|
|
‡a
estudiodelgenbmpr2enpacientesconhipertensionarterialpulmonar
‡A
Estudio del gen BMPR2 en pacientes con hipertensión arterial pulmonar
‡9
1
|
|
919
|
|
|
‡a
effectsoflungventilationperfusionandmusclemetabolismperfusionheterogeneitiesonmaximalo2transportandutilization
‡A
Effects of lung ventilation-perfusion and muscle metabolism-perfusion heterogeneities on maximal O2 transport and utilization
‡9
1
|
|
919
|
|
|
‡a
predictivemedicineoutcomeschallengesandopportunitiesinthesynergycopdproject
‡A
Predictive medicine: outcomes, challenges and opportunities in the Synergy-COPD project
‡9
1
|
|
919
|
|
|
‡a
serialrelationshipsbetweenventilationperfusioninequalityandspirometryinacutesevereasthmarequiringhospitalization
‡A
Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization
‡9
1
|
|
919
|
|
|
‡a
identificationandprospectivevalidationofclinicallyrelevantchronicobstructivepulmonarydiseasecopdsubtypes
‡A
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
‡9
1
|
|
919
|
|
|
‡a
lunginpatientswithcirrhosis
‡A
The lung in patients with cirrhosis
‡9
1
|
|
919
|
|
|
‡a
identificationofvascularprogenitorcellsinpulmonaryarteriesofpatientswithchronicobstructivepulmonarydisease
‡A
Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
impairedmuscleoxygentransferinpatientswithchronicrenalfailure
‡A
Impaired muscle oxygen transfer in patients with chronic renal failure
‡9
1
|
|
919
|
|
|
‡a
ventilatorycontrolindiabetesmellitus
‡A
Ventilatory control in diabetes mellitus
‡9
1
|
|
919
|
|
|
‡a
fromsystemsunderstandingtopersonalizedmedicinelessonsandrecommendationsbasedonamultidisciplinaryandtranslationalanalysisofcopd
‡A
From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.
‡9
1
|
|
919
|
|
|
‡a
studyofthebmpr2geneinpatientswithpulmonaryarterialhypertension
‡A
[Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
‡9
1
|
|
919
|
|
|
‡a
integratedcarepreventshospitalisationsforexacerbationsincopdpatients
‡A
Integrated care prevents hospitalisations for exacerbations in COPD patients
‡9
1
|
|
919
|
|
|
‡a
importanceofmitochondrialp
‡A
Importance of mitochondrial P
‡9
1
|
|
919
|
|
|
‡a
effectsofnebulizedn
‡A
Effects of nebulized N
‡9
1
|
|
919
|
|
|
‡a
gasexchangeandpulmonaryhemodynamicsduringlungresectioninpatientsatincreasedriskrelationshipwithpreoperativeexercisetesting
‡A
Gas exchange and pulmonary hemodynamics during lung resection in patients at increased risk: relationship with preoperative exercise testing
‡9
1
|
|
919
|
|
|
‡a
bronchialasthmaandaerosolbronchodilatorsincorrectuseinourmilieu
‡A
[Bronchial asthma and aerosol bronchodilators: incorrect use in our milieu]
‡9
1
|
|
919
|
|
|
‡a
plateletactivatingfactorcausesventilationperfusionmismatchinhumans
‡A
Platelet-activating factor causes ventilation-perfusion mismatch in humans
‡9
1
|
|
919
|
|
|
‡a
importanceofmitochondrialpo2inmaximalo2transportandutilizationatheoreticalanalysis
‡A
Importance of mitochondrial P(O2) in maximal O2 transport and utilization: a theoretical analysis
‡9
1
|
|
919
|
|
|
‡a
increaseinpulmonaryventilationperfusioninequalitywithageinhealthyindividuals
‡A
Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals
‡9
1
|
|
919
|
|
|
‡a
increasedtumournecrosisfactorαplasmalevelsduringmoderateintensityexerciseincopdpatients
‡A
Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients
‡9
1
|
|
919
|
|
|
‡a
inflammatoryreactioninpulmonarymusculararteriesofpatientswithmildchronicobstructivepulmonarydisease
‡A
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
effectofalmitrineonventilationperfusiondistributioninadultrespiratorydistresssyndrome
‡A
Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome
‡9
1
|
|
919
|
|
|
‡a
inhaledplateletactivatingfactorworsensgasexchangeinmildasthma
‡A
Inhaled platelet-activating factor worsens gas exchange in mild asthma.
‡9
1
|
|
919
|
|
|
‡a
roleofexternalandmatrixphinmitochondrialreactiveoxygenspeciesgeneration
‡A
The role of external and matrix pH in mitochondrial reactive oxygen species generation
‡9
1
|
|
919
|
|
|
‡a
bistabilityofmitochondrialrespirationunderliesparadoxicalreactiveoxygenspeciesgenerationinducedbyanoxia
‡A
Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia
‡9
1
|
|
919
|
|
|
‡a
oxygenfromtheatmospheretomitochondria
‡A
Oxygen: from the atmosphere to mitochondria
‡9
1
|
|
919
|
|
|
‡a
systemsbiologyapproachrevealsalinkbetweensystemiccytokinesandskeletalmuscleenergymetabolisminarodentsmokingmodelandhumancopd
‡A
A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.
‡9
1
|
|
919
|
|
|
‡a
physiologicalchangesinrespiratoryfunctionassociatedwithageing
‡A
Physiological changes in respiratory function associated with ageing
‡9
1
|
|
919
|
|
|
‡a
workforcepreparationthebiohealthcomputingmodelformasterandphdstudents
‡A
Workforce preparation: the Biohealth computing model for Master and PhD students
‡9
1
|
|
919
|
|
|
‡a
integratedcareserviceslessonslearnedfromthedeploymentofthenexesproject
‡A
Integrated care services: lessons learned from the deployment of the NEXES project
‡9
1
|
|
919
|
|
|
‡a
worseningofpulmonarygasexchangewithnitricoxideinhalationinchronicobstructivepulmonarydisease
‡A
Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
characteristicsofpatientswithsoybeandustinducedacutesevereasthmarequiringmechanicalventilation
‡A
Characteristics of patients with soybean dust-induced acute severe asthma requiring mechanical ventilation
‡9
1
|
|
919
|
|
|
‡a
expressionofbkcachannelsinhumanpulmonaryarteriesrelationshipwithremodelingandhypoxicpulmonaryvasoconstriction
‡A
Expression of BK(Ca) channels in human pulmonary arteries: relationship with remodeling and hypoxic pulmonary vasoconstriction
‡9
1
|
|
919
|
|
|
‡a
algorithmforautomaticforcedspirometryqualityassessmenttechnologicaldevelopments
‡A
Algorithm for automatic forced spirometry quality assessment: technological developments
‡9
1
|
|
919
|
|
|
‡a
interleukin8expressioninbronchoalveolarlavagecellsintheevaluationofalveolitisinidiopathicpulmonaryfibrosis
‡A
Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis.
‡9
1
|
|
919
|
|
|
‡a
isosorbide5mononitrateinthetreatmentofpulmonaryhypertensionassociatedwithportalhypertension
‡A
Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension
‡9
1
|
|
919
|
|
|
‡a
elevatedprevalenceofsubclinicalpulmonaryinvolvementinsystemiclupuserythematosus
‡A
[An elevated prevalence of subclinical pulmonary involvement in systemic lupus erythematosus]
‡9
1
|
|
919
|
|
|
‡a
enduranceexercisetrainingimprovesheartraterecoveryinpatientswithcopd
‡A
Endurance exercise training improves heart rate recovery in patients with COPD.
‡9
1
|
|
919
|
|
|
‡a
pneumocystispneumoniainhivantibodypositivepatients
‡A
Pneumocystis pneumonia in HIV antibody positive patients
‡9
1
|
|
919
|
|
|
‡a
predictionequationsforforcedspirometryfromeuropeanoriginpopulationsbarcelonacollaborativegrouponreferencevaluesforpulmonaryfunctiontestingandthespanishgroupoftheeuropeancommunityrespiratoryhealthsurvey
‡A
Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey.
‡9
1
|
|
919
|
|
|
‡a
pulmonaryhemodynamicsandgasexchangeduringexerciseinlivercirrhosis
‡A
Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis.
‡9
1
|
|
919
|
|
|
‡a
fatalairwaydiseaseinanadultwithchronicgraftversushostdisease
‡A
Fatal airway disease in an adult with chronic graft-versus-host disease
‡9
1
|
|
919
|
|
|
‡a
oxygenpathwaymodelingestimateshighreactiveoxygenspeciesproductionabovethehighestpermanenthumanhabitation
‡A
Oxygen pathway modeling estimates high reactive oxygen species production above the highest permanent human habitation
‡9
1
|
|
919
|
|
|
‡a
interplayofintrapulmonaryandextrapulmonaryfactorsonpulmonarygasexchangeduringweaning
‡A
Interplay of intrapulmonary and extrapulmonary factors on pulmonary gas exchange during weaning
‡9
1
|
|
919
|
|
|
‡a
adaptivecasemanagementsystemtosupportintegratedcareserviceslessonslearnedfromthenexesproject
‡A
An adaptive case management system to support integrated care services: Lessons learned from the NEXES project
‡9
1
|
|
919
|
|
|
‡a
dissociationofmaximalo2uptakefromo2deliveryincaninegastrocnemiusinsitu
‡A
Dissociation of maximal O2 uptake from O2 delivery in canine gastrocnemius in situ
‡9
1
|
|
919
|
|
|
‡a
systemsmedicinefrommolecularfeaturesandmodelstotheclinicincopd
‡A
Systems Medicine: from molecular features and models to the clinic in COPD.
‡9
1
|
|
919
|
|
|
‡a
doesoxidativestressmodulatelimbmuscleatrophyinseverecopdpatients
‡A
Does oxidative stress modulate limb muscle atrophy in severe COPD patients?
‡9
1
|
|
919
|
|
|
‡a
earlylungfunctionchangesaftershortheavyexposuretochrysotileasbestosinnonsmokingwomen
‡A
Early lung function changes after short heavy exposure to chrysotile asbestos in non-smoking women
‡9
1
|
|
919
|
|
|
‡a
oxyhemoglobinaffinityinpatientswithchronicobstructivepulmonarydiseaseandacuterespiratoryfailure
‡A
Oxyhemoglobin affinity in patients with chronic obstructive pulmonary disease and acute respiratory failure
‡9
1
|
|
919
|
|
|
‡a
echocardiographicabnormalitiesinpatientswithcopdattheir1hospitaladmission
‡A
Echocardiographic abnormalities in patients with COPD at their first hospital admission
‡9
1
|
|
919
|
|
|
‡a
salbutamolinhibitspulmonaryeffectsofplateletactivatingfactorinman
‡A
Salbutamol inhibits pulmonary effects of platelet activating factor in man.
‡9
1
|
|
919
|
|
|
‡a
noninvasiveassessmentofrespiratoryresistanceinseverechronicrespiratorypatientswithnasalcpap
‡A
Noninvasive assessment of respiratory resistance in severe chronic respiratory patients with nasal CPAP
‡9
1
|
|
919
|
|
|
‡a
effectofaplateletactivatingfactorpafantagonistsr27417aonpafinducedgasexchangeabnormalitiesinmildasthma
‡A
Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
‡9
1
|
|
919
|
|
|
‡a
pathophysiologyofmuscledysfunctionincopd
‡A
Pathophysiology of muscle dysfunction in COPD.
‡9
1
|
|
919
|
|
|
‡a
airpollutioneffectsintheelderlyintroduction
‡A
Air pollution effects in the elderly: introduction.
‡9
1
|
|
919
|
|
|
‡a
impactofhomehospitalizationonhealthcarecostsofexacerbationsincopdpatients
‡A
The impact of home hospitalization on healthcare costs of exacerbations in COPD patients
‡9
1
|
|
919
|
|
|
‡a
sustainedventriculartachycardiaasamarkerofinadequatemyocardialperfusionduringtheacutephaseofmyocardialinfarction
‡A
Sustained ventricular tachycardia as a marker of inadequate myocardial perfusion during the acute phase of myocardial infarction
‡9
1
|
|
919
|
|
|
‡a
peakoxygenuptakeduringthe6minutewalktestindiffuseinterstitiallungdiseaseandpulmonaryhypertension
‡A
Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension
‡9
1
|
|
919
|
|
|
‡a
safetyofparecoxibinasthmaticpatientswithaspirinexacerbatedrespiratorydisease
‡A
Safety of Parecoxib in Asthmatic Patients with Aspirin-Exacerbated Respiratory Disease
‡9
1
|
|
919
|
|
|
‡a
effectofnitricoxideinhalationongasexchangeinacuteseverepneumonia
‡A
Effect of nitric oxide inhalation on gas exchange in acute severe pneumonia
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeresponsetoexerciseandmannitolinducedbronchoconstrictioninmildasthma
‡A
Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma
‡9
1
|
|
919
|
|
|
‡a
effectivenessofcommunitybasedintegratedcareinfrailcopdpatientsarandomisedcontrolledtrial
‡A
Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial
‡9
1
|
|
919
|
|
|
‡a
systemsmedicineandintegratedcaretocombatchronicnoncommunicablediseases
‡A
Systems medicine and integrated care to combat chronic noncommunicable diseases
‡9
1
|
|
919
|
|
|
‡a
clinicaldecisionsupportsystemtoenhancequalitycontrolofspirometryusinginformationandcommunicationtechnologies
‡A
Clinical decision support system to enhance quality control of spirometry using information and communication technologies
‡9
1
|
|
919
|
|
|
‡a
salbutamolreducespulmonaryneutrophilsequestrationofplateletactivatingfactorinhumans
‡A
Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans
‡9
1
|
|
919
|
|
|
‡a
compartmentationofglycogenmetabolismrevealedfrom13cisotopologuedistributions
‡A
Compartmentation of glycogen metabolism revealed from 13C isotopologue distributions
‡9
1
|
|
919
|
|
|
‡a
systemiceffectsofcigarettesmokeexposureintheguineapig
‡A
Systemic effects of cigarette smoke exposure in the guinea pig.
‡9
1
|
|
919
|
|
|
‡a
effectsandbarrierstodeploymentoftelehealthwellnessprogramsforchronicpatientsacross3europeancountries
‡A
Effects and barriers to deployment of telehealth wellness programs for chronic patients across 3 European countries
‡9
1
|
|
919
|
|
|
‡a
guidelinesfordevelopingsuccessfulshortadvancedcoursesinsystemsmedicineandsystemsbiology
‡A
Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology
‡9
1
|
|
919
|
|
|
‡a
circulatingprogenitorcellsandvasculardysfunctioninchronicobstructivepulmonarydisease
‡A
Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
glutathionedepletionimpairsmyogenicdifferentiationofmurineskeletalmusclec2c12cellsthroughsustainednfkappabactivation
‡A
Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation
‡9
1
|
|
919
|
|
|
‡a
copdexacerbationswhoissafetobemanagedathome
‡A
COPD exacerbations: who is safe to be managed at home
‡9
1
|
|
919
|
|
|
‡a
fluticasonepropionateattenuatesplateletactivatingfactorinducedgasexchangedefectsinmildasthma
‡A
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma
‡9
1
|
|
919
|
|
|
‡a
roleofperipheralmusclesonexercisetoleranceinpatientswithcopd
‡A
The role of peripheral muscles on exercise tolerance in patients with COPD
‡9
1
|
|
919
|
|
|
‡a
characterizationofpulmonaryvascularremodellinginsmokersandpatientswithmildcopd
‡A
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.
‡9
1
|
|
919
|
|
|
‡a
enhancedexpressionofvascularendothelialgrowthfactorinpulmonaryarteriesofsmokersandpatientswithmoderatechronicobstructivepulmonarydisease
‡A
Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
personalisedprehabilitationinhighriskpatientsundergoingelectivemajorabdominalsurgeryarandomizedblindedcontrolledtrial
‡A
Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial
‡9
1
|
|
919
|
|
|
‡a
contributionofmultipleinertgaseliminationtechniquetopulmonarymedicine1principlesandinformationcontentofthemultipleinertgaseliminationtechnique
‡A
Contribution of multiple inert gas elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique
‡9
1
|
|
919
|
|
|
‡a
telemedicinebasedapproachforobstructivesleepapneamanagementbuildingevidence
‡A
Telemedicine-based approach for obstructive sleep apnea management: building evidence.
‡9
1
|
|
919
|
|
|
‡a
biomedicalresearchinadigitalhealthframework
‡A
Biomedical research in a Digital Health Framework
‡9
1
|
|
919
|
|
|
‡a
effectsofinhalednitricoxideatrestandduringexerciseinidiopathicpulmonaryfibrosis
‡A
Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis
‡9
1
|
|
919
|
|
|
‡a
standardizationofthemeasurementoftransferfactordiffusingcapacityworkgrouponstandardizationofrespiratoryfunctiontestseuropeancommunityforcoalandsteelofficialpositionoftheeuropeanrespiratorysociety
‡A
[Standardization of the measurement of transfer factor (diffusing capacity). Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]
‡9
1
|
|
919
|
|
|
‡a
standardizationofthemeasurementoftransferfactor
‡A
[Standardization of the measurement of transfer factor
‡9
1
|
|
919
|
|
|
‡a
globalmuscledysfunctionasariskfactorofreadmissiontohospitalduetocopdexacerbations
‡A
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations
‡9
1
|
|
919
|
|
|
‡a
physiologicalresponsestothe6minwalktestinpatientswithchronicobstructivepulmonarydisease
‡A
Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
spirometricresponsetoabronchodilatorreferencevaluesforhealthychildrenandadolescents
‡A
Spirometric response to a bronchodilator. Reference values for healthy children and adolescents
‡9
1
|
|
919
|
|
|
‡a
geneticvariantsofmicrosomalepoxidehydrolaseandglutamatecysteineligaseincopd
‡A
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.
‡9
1
|
|
919
|
|
|
‡a
limitationofmaximalo2uptakeandperformancebyacutehypoxiaindogmuscleinsitu
‡A
Limitation of maximal O2 uptake and performance by acute hypoxia in dog muscle in situ
‡9
1
|
|
919
|
|
|
‡a
ventilationperfusionimbalanceandchronicobstructivepulmonarydiseasestagingseverity
‡A
Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity
‡9
1
|
|
919
|
|
|
‡a
personalizedrespiratorymedicineexploringthehorizonaddressingtheissuessummaryofabrnajrccmworkshopheldinbarcelonaonjune12
‡A
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014
‡9
1
|
|
919
|
|
|
‡a
proposalsforenhancedhealthriskassessmentandstratificationinanintegratedcarescenario
‡A
Proposals for enhanced health risk assessment and stratification in an integrated care scenario
‡9
1
|
|
919
|
|
|
‡a
effectsofnoninvasiveventilationonpulmonarygasexchangeandhemodynamicsduringacutehypercapnicexacerbationsofchronicobstructivepulmonarydisease
‡A
Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
gasexchangeresponsetoshortactingbeta2agonistsinchronicobstructivepulmonarydiseasesevereexacerbations
‡A
Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations
‡9
1
|
|
919
|
|
|
‡a
contributionsofmultipleinertgaseliminationtechniquetopulmonarymedicine3bronchialasthma
‡A
Contributions of multiple inert gas elimination technique to pulmonary medicine.3. Bronchial asthma
‡9
1
|
|
919
|
|
|
‡a
angiogenicgrowthfactormrnaresponsestopassiveandcontractioninducedhyperperfusioninskeletalmuscle
‡A
Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscle
‡9
1
|
|
919
|
|
|
‡a
muscleangiogenicgrowthfactorgeneresponsestoexerciseinchronicrenalfailure
‡A
Muscle angiogenic growth factor gene responses to exercise in chronic renal failure
‡9
1
|
|
919
|
|
|
‡a
predictionequationsforplethysmographiclungvolumes
‡A
Prediction equations for plethysmographic lung volumes.
‡9
1
|
|
919
|
|
|
‡a
formoterolprotectsagainstplateletactivatingfactorinducedeffectsinasthma
‡A
Formoterol protects against platelet-activating factor-induced effects in asthma
‡9
1
|
|
919
|
|
|
‡a
gasexchangeresponsetoapafreceptorantagonistsr27417ainacuteasthmaapilotstudy
‡A
Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study
‡9
1
|
|
919
|
|
|
‡a
gasexchangemechanismoforthodeoxiainhepatopulmonarysyndrome
‡A
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome
‡9
1
|
|
919
|
|
|
‡a
officialamericanthoracicsocietyeuropeanrespiratorysocietystatementupdateonlimbmuscledysfunctioninchronicobstructivepulmonarydisease
‡A
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
systemsbiologyapproachidentifiesmolecularnetworksdefiningskeletalmuscleabnormalitiesinchronicobstructivepulmonarydisease
‡A
A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
pulmonaryvascularabnormalitiesandventilationperfusionrelationshipsinmildchronicobstructivepulmonarydisease
‡A
Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
clinicalandfunctionalcharacteristicsofpatients2yearsafterbeingaffectedbythesoybeanasthmaepidemicinbarcelona
‡A
Clinical and functional characteristics of patients two years after being affected by the soybean asthma epidemic in Barcelona
‡9
1
|
|
919
|
|
|
‡a
gasexchangeduringexerciseinmildchronicobstructivepulmonarydiseasecorrelationwithlungstructure
‡A
Gas exchange during exercise in mild chronic obstructive pulmonary disease. Correlation with lung structure
‡9
1
|
|
919
|
|
|
‡a
correlationofbronchoalveolarlavageandclinicalandfunctionalfindingsinasbestosis
‡A
Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis
‡9
1
|
|
919
|
|
|
‡a
chainrankachainprioritisationmethodforcontextualisationofbiologicalnetworks
‡A
ChainRank, a chain prioritisation method for contextualisation of biological networks
‡9
1
|
|
919
|
|
|
‡a
cryptichaplotypesofserpina1confersusceptibilitytochronicobstructivepulmonarydisease
‡A
Cryptic haplotypes ofSERPINA1confer susceptibility to chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
newsolutionsforpersonalisedhealthmanagementcitizensneedshealthcarechangesandmarketperspectivesroundtabledebate
‡A
New solutions for personalised health management: citizens' needs, healthcare changes, and market perspectives round table debate
‡9
1
|
|
919
|
|
|
‡a
workgrouponstandardizationofrespiratoryfunctiontestseuropeancommunityforcoalandsteelofficialpositionoftheeuropeanrespiratorysociety
‡A
Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeresponsestohistamineandmethacholinechallengesinmildasthma
‡A
Pulmonary gas exchange responses to histamine and methacholine challenges in mild asthma
‡9
1
|
|
919
|
|
|
‡a
respiratoryresponsetochemicalstimuliandexercisecapacityunderconditionsofacutehypoxiainelitemountainclimbers
‡A
[Respiratory response to chemical stimuli and exercise capacity under conditions of acute hypoxia in elite mountain climbers]
‡9
1
|
|
919
|
|
|
‡a
benignpleurisycausedbyasbestos
‡A
[Benign pleurisy caused by asbestos]
‡9
1
|
|
919
|
|
|
‡a
benefitsofphysicalactivityoncopdhospitalisationdependonintensity
‡A
Benefits of physical activity on COPD hospitalisation depend on intensity
‡9
1
|
|
919
|
|
|
‡a
belowwhatfev1shouldarterialbloodberoutinelytakentodetectchronicrespiratoryfailureincopd
‡A
Below what FEV1 should arterial blood be routinely taken to detect chronic respiratory failure in COPD?
‡9
1
|
|
919
|
|
|
‡a
synergycopdasystemsapproachforunderstandingandmanagingchronicdiseases
‡A
Synergy-COPD: a systems approach for understanding and managing chronic diseases
‡9
1
|
|
919
|
|
|
‡a
pulmonaryfunctiontestsandctscaninthemanagementofidiopathicpulmonaryfibrosis
‡A
Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeandsputumcellularresponsestoinhaledleukotriene500
‡A
Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D
‡9
1
|
|
919
|
|
|
‡a
curedmeatconsumptionincreasesriskofreadmissionincopdpatients
‡A
Cured meat consumption increases risk of readmission in COPD patients
‡9
1
|
|
919
|
|
|
‡a
pulmonaryventilatorydefectsandoccupationalexposuresinapopulationbasedstudyinspainspanishgroupoftheeuropeancommunityrespiratoryhealthsurvey
‡A
Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Spanish Group of the European Community Respiratory Health Survey
‡9
1
|
|
919
|
|
|
‡a
quadricepsmuscleweaknessandatrophyareassociatedwithadifferentialepigeneticprofileinadvancedcopd
‡A
Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
‡9
1
|
|
919
|
|
|
‡a
clinicaldecisionsupportsystemscdssforpreventivemanagementofcopdpatients
‡A
Clinical Decision Support Systems (CDSS) for preventive management of COPD patients
‡9
1
|
|
919
|
|
|
‡a
effectsofintervalandcontinuousexercisetrainingonautonomiccardiacfunctionincopdpatients
‡A
Effects of interval and continuous exercise training on autonomic cardiac function in COPD patients
‡9
1
|
|
919
|
|
|
‡a
effectofacetylsalicylicacidonpulmonarygasexchangeinpatientswithseverepneumonia
‡A
Effect of Acetylsalicylic Acid on Pulmonary Gas Exchange in Patients With Severe Pneumonia
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeandsputumcellularresponsestoinhaledleukotriene5004inasthma
‡A
Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma
‡9
1
|
|
919
|
|
|
‡a
reactiveoxygenspeciesproductionbyforwardandreverseelectronfluxesinthemitochondrialrespiratorychain
‡A
Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain
‡9
1
|
|
919
|
|
|
‡a
readmeplease
‡A
[Read me, please!]
‡9
1
|
|
919
|
|
|
‡a
reducedexpressionofendothelialnitricoxidesynthaseinpulmonaryarteriesofsmokers
‡A
Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers
‡9
1
|
|
919
|
|
|
‡a
responsetohypoxiaofpulmonaryarteriesinchronicobstructivepulmonarydiseaseaninvitrostudy
‡A
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
‡9
1
|
|
919
|
|
|
‡a
adjustmentofdlcoforhemoglobinconcentration
‡A
Adjustment of DLCO for hemoglobin concentration.
‡9
1
|
|
919
|
|
|
‡a
effectsoffio2onlegvo2duringcycleergometryinsedentarysubjects
‡A
Effects of FIO2 on leg ??VO2 during cycle ergometry in sedentary subjects
‡9
1
|
|
919
|
|
|
‡a
reducedmuscleredoxcapacityafterendurancetraininginpatientswithchronicobstructivepulmonarydisease
‡A
Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
referencesvaluesforforcedspirometrygroupoftheeuropeancommunityrespiratoryhealthsurvey
‡A
References values for forced spirometry. Group of the European Community Respiratory Health Survey.
‡9
1
|
|
919
|
|
|
‡a
determinantsofexercisecapacityinobeseandnonobesecopdpatients
‡A
Determinants of exercise capacity in obese and non-obese COPD patients
‡9
1
|
|
919
|
|
|
‡a
fromcomorbiditiesofchronicobstructivepulmonarydiseasetoidentificationofsharedmolecularmechanismsbydataintegration
‡A
From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration
‡9
1
|
|
919
|
|
|
‡a
testingthemeasurementpropertiesofthespanishversionofthesf36healthsurveyamongmalepatientswithchronicobstructivepulmonarydisease
‡A
Testing the Measurement Properties of the Spanish Version of the SF-36 Health Survey Among Male Patients with Chronic Obstructive Pulmonary Disease
‡9
1
|
|
919
|
|
|
‡a
bacterialcolonizationasapotentialsourceofnosocomialrespiratoryinfectionsin2typesofspirometer
‡A
Bacterial colonization as a potential source of nosocomial respiratory infections in two types of spirometer
‡9
1
|
|
919
|
|
|
‡a
pulmonarygasexchangeinseverechronicasthmaresponseto100oxygenandsalbutamol
‡A
Pulmonary gas exchange in severe chronic asthma. Response to 100% oxygen and salbutamol
‡9
1
|
|
919
|
|
|
‡a
effectsofaltitudeacclimatizationonpulmonarygasexchangeduringexercise
‡A
Effects of altitude acclimatization on pulmonary gas exchange during exercise
‡9
1
|
|
919
|
|
|
‡a
effectsofanintegratedcareinterventiononriskfactorsofcopdreadmission
‡A
Effects of an integrated care intervention on risk factors of COPD readmission
‡9
1
|
|
919
|
|
|
‡a
burdenofchronicdisordersonhospitaladmissionspromptstheneedfornewmodalitiesofcareacrosssectionalanalysisinatertiaryhospital
‡A
The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital
‡9
1
|
|
919
|
|
|
‡a
systemsmedicineclinicalplatformforunderstandingandmanagingnoncommunicablediseases
‡A
A systems medicine clinical platform for understanding and managing non- communicable diseases.
‡9
1
|
|
919
|
|
|
‡a
determinationofthedistributionofventilationperfusionratiostechnicofeliminationofmultipleinertgases
‡A
[Determination of the distribution of ventilation-perfusion ratios: technic of elimination of multiple inert gases]
‡9
1
|
|
919
|
|
|
‡a
copdknowledgebaseenablingdataanalysisandcomputationalsimulationintranslationalcopdresearch
‡A
The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research
‡9
1
|
|
919
|
|
|
‡a
clinicalvalueofvasodilatortestwithinhalednitricoxideforpredictinglongtermresponsetooralvasodilatorsinpulmonaryhypertension
‡A
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension
‡9
1
|
|
919
|
|
|
‡a
protocolforregionalimplementationofcollaborativelungfunctiontesting
‡A
Protocol for regional implementation of collaborative lung function testing
‡9
1
|
|
919
|
|
|
‡a
effectsofendurancetrainingonskeletalmusclebioenergeticsinchronicobstructivepulmonarydisease
‡A
Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
cellularbioenergeticsaftererythropoietintherapyinchronicrenalfailure
‡A
Cellular bioenergetics after erythropoietin therapy in chronic renal failure.
‡9
1
|
|
919
|
|
|
‡a
lungfunctionchangesfollowinglegionnairesdisease
‡A
Lung function changes following Legionnaires' disease
‡9
1
|
|
919
|
|
|
‡a
effectsof5lipoxygenaseinhibitionbyzileutononplateletactivatingfactorinducedpulmonaryabnormalitiesinmildasthma
‡A
The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma
‡9
1
|
|
919
|
|
|
‡a
physicalexerciseincreasesportalpressureinpatientswithcirrhosisandportalhypertension
‡A
Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension
‡9
1
|
|
919
|
|
|
‡a
anotherasthmaoutbreakinbarcelonaroleofoxidesofnitrogen
‡A
Another asthma outbreak in Barcelona: role of oxides of nitrogen
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2014
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
947
|
|
|
‡a
ES
‡9
1
|
|
996
|
|
|
‡2
BNE|XX1037532
|
|
996
|
|
|
‡2
SUDOC|07500433X
|
|
996
|
|
|
‡2
BNCHL|10000000000000000088447
|
|
996
|
|
|
‡2
ISNI|000000042767315X
|
|
996
|
|
|
‡2
BNE|XX6127089
|
|
996
|
|
|
‡2
NUKAT|n 2006145463
|
|
996
|
|
|
‡2
LC|no2019147823
|
|
996
|
|
|
‡2
BNE|XX1694126
|
|
996
|
|
|
‡2
BNF|16731226
|
|
996
|
|
|
‡2
BNE|XX5407557
|
|
996
|
|
|
‡2
SUDOC|083064516
|
|
996
|
|
|
‡2
LC|no2011022229
|
|
996
|
|
|
‡2
LC|ns2013000042
|
|
996
|
|
|
‡2
ISNI|0000000043093420
|
|
996
|
|
|
‡2
BNE|XX1094476
|
|
996
|
|
|
‡2
BNF|12819599
|
|
996
|
|
|
‡2
BNC|981058509382506706
|
|
996
|
|
|
‡2
RERO|A003752523
|
|
996
|
|
|
‡2
DNB|112111122X
|
|
996
|
|
|
‡2
BNE|XX991636
|
|
996
|
|
|
‡2
BNE|XX1687618
|
|
996
|
|
|
‡2
BNCHL|10000000000000000827759
|
|
996
|
|
|
‡2
ISNI|0000000059293347
|
|
996
|
|
|
‡2
BNE|XX1028415
|
|
996
|
|
|
‡2
BNC|981058609127806706
|
|
996
|
|
|
‡2
LC|n 97023303
|
|
996
|
|
|
‡2
NTA|072689226
|
|
996
|
|
|
‡2
SUDOC|099262401
|
|
996
|
|
|
‡2
BAV|495_185641
|
|
996
|
|
|
‡2
BNF|12205947
|
|
996
|
|
|
‡2
BNE|XX1011746
|
|
996
|
|
|
‡2
BNCHL|10000000000000000060156
|
|
996
|
|
|
‡2
BNF|16745273
|
|
996
|
|
|
‡2
BNE|XX4872283
|
|
996
|
|
|
‡2
SUDOC|144856727
|
|
996
|
|
|
‡2
LC|n 85261035
|
|
996
|
|
|
‡2
LC|n 2002016098
|
|
996
|
|
|
‡2
LC|no 94021048
|
|
996
|
|
|
‡2
BNE|XX4950393
|
|
996
|
|
|
‡2
LC|no2016064262
|
|
996
|
|
|
‡2
PTBNP|1579250
|
|
996
|
|
|
‡2
LC|n 88114918
|
|
996
|
|
|
‡2
BNE|XX1731004
|
|
996
|
|
|
‡2
BNE|XX980095
|
|
996
|
|
|
‡2
ISNI|0000000059259763
|
|
996
|
|
|
‡2
ISNI|0000000083987613
|
|
996
|
|
|
‡2
BNC|981058527741906706
|
|
996
|
|
|
‡2
SUDOC|104512563
|
|
996
|
|
|
‡2
BIBSYS|97041939
|
|
996
|
|
|
‡2
BNC|981058516394906706
|
|
996
|
|
|
‡2
NYNYRILM|343429
|
|
996
|
|
|
‡2
LC|n 84202950
|
|
996
|
|
|
‡2
NTA|132167751
|
|
996
|
|
|
‡2
ISNI|0000000115503557
|
|
996
|
|
|
‡2
RERO|A002976119
|
|
996
|
|
|
‡2
ISNI|0000000400139977
|
|
996
|
|
|
‡2
LC|n 88001619
|
|
996
|
|
|
‡2
BNE|XX904756
|
|
996
|
|
|
‡2
ISNI|0000000037126564
|
|
996
|
|
|
‡2
BNC|981058511908806706
|
|
996
|
|
|
‡2
CAOONL|ncf11301727
|
|
996
|
|
|
‡2
BNF|12494118
|
|
996
|
|
|
‡2
LC|no2010128912
|
|
996
|
|
|
‡2
BNC|981058516740406706
|
|
996
|
|
|
‡2
ISNI|0000000025660735
|
|
996
|
|
|
‡2
BNF|16963673
|
|
996
|
|
|
‡2
BNC|981061085839106706
|
|
996
|
|
|
‡2
NTA|071226133
|
|
996
|
|
|
‡2
BNE|XX981609
|
|
996
|
|
|
‡2
ISNI|000000045100727X
|
|
996
|
|
|
‡2
BNC|981058509360906706
|
|
996
|
|
|
‡2
BIBSYS|2078572
|
|
996
|
|
|
‡2
BNC|981058515845306706
|
|
996
|
|
|
‡2
BNC|981060934968006706
|
|
996
|
|
|
‡2
CAOONL|ncf10516006
|
|
996
|
|
|
‡2
BNE|XX1327548
|
|
996
|
|
|
‡2
BNE|XX1026723
|
|
996
|
|
|
‡2
BNC|981058517538406706
|
|
996
|
|
|
‡2
DNB|110305760X
|
|
996
|
|
|
‡2
BNE|XX1116429
|
|
996
|
|
|
‡2
SUDOC|030010225
|
|
996
|
|
|
‡2
BNCHL|10000000000000000200536
|
|
996
|
|
|
‡2
ISNI|0000000032587345
|
|
996
|
|
|
‡2
BNE|XX1019280
|
|
996
|
|
|
‡2
BNE|XX920005
|
|
996
|
|
|
‡2
BNE|XX5502698
|
|
996
|
|
|
‡2
BNE|XX953988
|
|
996
|
|
|
‡2
BNE|XX1581791
|
|
996
|
|
|
‡2
BNF|15505225
|
|
996
|
|
|
‡2
BAV|495_249509
|
|
996
|
|
|
‡2
NTA|075171473
|
|
996
|
|
|
‡2
BNC|981058616277406706
|
|
996
|
|
|
‡2
SUDOC|088392511
|
|
996
|
|
|
‡2
RERO|A000006270
|
|
996
|
|
|
‡2
BNC|981058514992506706
|
|
996
|
|
|
‡2
BNC|981058519139306706
|
|
996
|
|
|
‡2
ISNI|0000000110936214
|
|
996
|
|
|
‡2
NUKAT|n 2012210962
|
|
996
|
|
|
‡2
LC|nr 95011290
|
|
996
|
|
|
‡2
LC|n 80153605
|
|
996
|
|
|
‡2
RERO|A000158559
|
|
996
|
|
|
‡2
ISNI|0000000039717771
|
|
996
|
|
|
‡2
BNC|981058514499806706
|
|
996
|
|
|
‡2
BNC|981058524422806706
|
|
996
|
|
|
‡2
BNE|XX920349
|
|
996
|
|
|
‡2
RERO|A018028914
|
|
996
|
|
|
‡2
BNE|XX896907
|
|
996
|
|
|
‡2
BNE|XX1421285
|
|
996
|
|
|
‡2
LC|n 2024035447
|
|
996
|
|
|
‡2
BNCHL|10000000000000000843055
|
|
996
|
|
|
‡2
BNF|14433400
|
|
996
|
|
|
‡2
BNC|981058517374506706
|
|
996
|
|
|
‡2
BNF|14409424
|
|
996
|
|
|
‡2
BNE|XX5618690
|
|
996
|
|
|
‡2
DNB|1157186971
|
|
996
|
|
|
‡2
ISNI|0000000059879364
|
|
996
|
|
|
‡2
BNC|981061056955606706
|
|
996
|
|
|
‡2
SUDOC|031704794
|
|
996
|
|
|
‡2
LC|nr2003008329
|
|
996
|
|
|
‡2
DNB|143289322
|
|
996
|
|
|
‡2
DNB|1056790024
|
|
996
|
|
|
‡2
BNCHL|10000000000000000842546
|
|
996
|
|
|
‡2
ISNI|0000000044635164
|
|
996
|
|
|
‡2
NII|DA10017837
|
|
996
|
|
|
‡2
RERO|A000138364
|
|
996
|
|
|
‡2
ISNI|0000000059837914
|
|
996
|
|
|
‡2
DNB|1266123679
|
|
996
|
|
|
‡2
BNF|12287006
|
|
996
|
|
|
‡2
LC|n 96009950
|
|
996
|
|
|
‡2
SUDOC|241044456
|
|
996
|
|
|
‡2
LC|ns2012004665
|
|
996
|
|
|
‡2
BNCHL|10000000000000000098671
|
|
996
|
|
|
‡2
RERO|A010141679
|
|
996
|
|
|
‡2
BIBSYS|90352968
|
|
996
|
|
|
‡2
BNC|981058526294206706
|
|
996
|
|
|
‡2
SUDOC|030694949
|
|
996
|
|
|
‡2
PTBNP|644774
|
|
996
|
|
|
‡2
LC|n 94120576
|
|
996
|
|
|
‡2
BNE|XX929731
|
|
996
|
|
|
‡2
LC|ns2024003282
|
|
996
|
|
|
‡2
NII|DA18889510
|
|
996
|
|
|
‡2
RERO|A003752524
|
|
996
|
|
|
‡2
ISNI|0000000116052794
|
|
996
|
|
|
‡2
BIBSYS|7079754
|
|
996
|
|
|
‡2
BNC|981058507651106706
|
|
996
|
|
|
‡2
BIBSYS|1014995
|
|
996
|
|
|
‡2
BNC|981058527725606706
|
|
996
|
|
|
‡2
BNE|XX1224517
|
|
996
|
|
|
‡2
SUDOC|079552374
|
|
996
|
|
|
‡2
BNC|981058515033406706
|
|
996
|
|
|
‡2
DNB|115723027X
|
|
996
|
|
|
‡2
NSK|000599689
|
|
996
|
|
|
‡2
ISNI|0000000079726883
|
|
996
|
|
|
‡2
DNB|1147182035
|
|
996
|
|
|
‡2
DNB|1157169414
|
|
996
|
|
|
‡2
LC|ns2012002726
|
|
996
|
|
|
‡2
BNF|16585857
|
|
996
|
|
|
‡2
BNE|XX1091108
|
|
996
|
|
|
‡2
LC|n 91110999
|
|
996
|
|
|
‡2
BNE|XX4841670
|
|
996
|
|
|
‡2
LC|ns2016000172
|
|
996
|
|
|
‡2
B2Q|0000474934
|
|
996
|
|
|
‡2
SELIBR|197768
|
|
996
|
|
|
‡2
BNE|XX941805
|
|
996
|
|
|
‡2
BNCHL|10000000000000000168031
|
|
996
|
|
|
‡2
LC|n 82140935
|
|
996
|
|
|
‡2
BNE|XX1531864
|
|
996
|
|
|
‡2
RERO|A011601262
|
|
996
|
|
|
‡2
ISNI|0000000059554551
|
|
996
|
|
|
‡2
BNC|981058615918306706
|
|
996
|
|
|
‡2
BNE|XX5221166
|
|
996
|
|
|
‡2
SUDOC|083906401
|
|
996
|
|
|
‡2
BNE|XX1398842
|
|
996
|
|
|
‡2
RERO|A006126274
|
|
996
|
|
|
‡2
BNE|XX1041050
|
|
996
|
|
|
‡2
LC|no2012041246
|
|
996
|
|
|
‡2
BNF|12524547
|
|
996
|
|
|
‡2
DNB|1108556426
|
|
996
|
|
|
‡2
ISNI|0000000059196272
|
|
996
|
|
|
‡2
BNC|981058601801606706
|
|
996
|
|
|
‡2
NUKAT|n 2017036745
|
|
996
|
|
|
‡2
DNB|1315354128
|
|
996
|
|
|
‡2
BNC|981058609751106706
|
|
996
|
|
|
‡2
ISNI|0000000378223522
|
|
996
|
|
|
‡2
RERO|A003518725
|
|
996
|
|
|
‡2
BNC|981058517780506706
|
|
996
|
|
|
‡2
LC|n 86824126
|
|
996
|
|
|
‡2
RERO|A017603338
|
|
996
|
|
|
‡2
SUDOC|182331849
|
|
996
|
|
|
‡2
DNB|1159005079
|
|
996
|
|
|
‡2
RERO|A003752518
|
|
996
|
|
|
‡2
RERO|A003752519
|
|
997
|
|
|
‡a
1952 0 lived 0000 0
‡9
1
|
|
998
|
|
|
‡a
Roca, Josep
‡2
ISNI|0000000030171653
‡3
suggested
|
|
998
|
|
|
‡a
Roca Torrent, Josep
‡2
ISNI|0000000030171653
‡3
suggested
|
|
998
|
|
|
‡a
Roca, Josep
‡2
ISNI|0000000030171653
‡3
suggested
|
|
998
|
|
|
‡a
Roca, Josep
‡2
BNE|XX5136844
‡3
suggested
‡3
single date
‡3
title: (0.64, 'enfermedadpulmonarobstructivacronicaepocguiainteractivaparapacientesconenfermedadesdelargaduracion', 'actividadesdelavidadiariaenpacientesconenfermedadpulmonarobstructivacronicavalidaciondelatraduccionespanolayanalisiscomparativode2cuestionarios')
|
|
998
|
|
|
‡a
Roca, Josep
‡2
BIBSYS|2078572
‡3
single date
‡3
viafid
|
|
998
|
|
|
‡a
Roca Torrent, Josep
‡2
BNE|XX904756
‡3
suggested
|
|
998
|
|
|
‡a
Roca Torrent, Josep
‡2
BNC|981058510674406706
‡3
standard number
|
|
998
|
|
|
‡a
Roca, Josep
‡2
DNB|1108556426
‡3
suggested
‡3
single date
|
|
998
|
|
|
‡a
Roca, Josep
‡2
NUKAT|n 2017036745
‡3
suggested
‡3
viafid
‡3
single date
|
